A circuit clot is one of the most frequent complications during extracorporeal membrane oxygenation (ECMO) support. We identify coagulation/fibrinolysis markers for predicting ECMO circuit exchange because of circuit clots during ECMO support. Ten patients with acute pulmonary failure who underwent veno-venous ECMO were enrolled between January 2014 and December 2016. ECMO support lasted 106 days. The 6 days on which the ECMO circuits were exchanged were considered as circuit clot (+) group, while the remaining 100 days were considered as circuit clot (−) group. The predictors of ECMO circuit exchange because of circuit clots were identified. The mean duration of ECMO support was 10 ± 13 days, and the mean number of ECMO circuit exchange was 0.6 ± 1.1 times per patient. Thrombin-antithrombin complex (TAT) and soluble fibrin (SF) were higher in the circuit clot (+) group than in the circuit clot (−) group (both P < 0.01). According to a multivariate analysis, SF was the only independent predictor of ECMO circuit exchange (P < 0.01). The odds ratio (confidence intervals) for SF (10 µg/ml) was 1.20 (1.06–1.36). The area under the curve and optimal cut-off value were 0.95 and 101 ng/ml for SF (sensitivity, 100%; specificity, 89%). SF may be useful in predicting ECMO circuit exchange because of circuit clots.
Circuit clot ECMO SF Hemolysis
This is a preview of subscription content, log in to check access.
Compliance with ethical standards
Conflict of interest
The authors declare that there is no conflict of interest.
Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilator support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicenter randomized controlled trial. Lancet. 2009;374:1351–63.CrossRefPubMedGoogle Scholar
Brogan TV, Thiaharajan RR, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Med. 2009;35:2105–14.CrossRefPubMedGoogle Scholar
Kolla S, Awad SS, Rich PB, et al. Extracorporeal life support for 100 adult patients with severe respiratory failure. Ann Surg. 1997;226:565–6.CrossRefGoogle Scholar
Lubnow M, Philipp A, Dornia C, et al. d-dimer as an early marker for oxygenator exchange in extracorporeal membrane oxygenation. J Crit Care 2014;29:473.e1-5.CrossRefPubMedGoogle Scholar
Arnold P, Jackson S, Wallis J, et al. Coagulation factor activity during neonatal extracorporeal membrane oxygenation. Intensive Care Med. 2001;27:1395–400.CrossRefPubMedGoogle Scholar
Dornia C, Philipp A, Bauer S, et al. d-dimer are a predictor of clot volume inside membrane oxygenators during extracorporeal membrane oxygenation. Artif Organs. 2015;39:782–7.CrossRefPubMedGoogle Scholar
Dempfle CE. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state. Thromb Haemost. 1999;82:673–83.CrossRefPubMedGoogle Scholar
Tsuji A, Wada H, Matsumoto T, et al. Elevated levels of soluble fibrin in patients with venous thromboembolism. Int J Hematol. 2008;88:448–53.CrossRefPubMedGoogle Scholar
Sudo A, Wada H, Nobori T, et al. Cut-off values of d-dimer and soluble fibrin for prediction of deep vein thrombosis after orthopaedic surgery. Int J Hematol. 2009;89:572–6.CrossRefPubMedGoogle Scholar